Evaluation of PIVKA-II efficiency in the diagnosis of early hepatocellular carcinoma

被引：0
|
作者：
Saitta, Carlo [2 ]
Raffa, Giuseppina [2 ]
di Tocco, Francesca Casuscelli [2 ]
Brancatelli, Santa [2 ]
Alibrandi, Angela [3 ]
Raimondo, Giovanni [2 ]
Pollicino, Teresa [1 ]
机构：
[1] Univ Hosp Messina, Pediat Gynecol Microbiol & Biomed Sci, Messina, Italy
[2] Univ Hosp Messina, Clin & Expt Med, Messina, Italy
[3] Univ Messina, Messina, Italy
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1898
引用
收藏
页码：1134A / 1134A
页数：1
相关论文
共 50 条
  • [1] PIVKA-II IS A USEFUL TOOL FOR THE DIAGNOSIS OF EARLY HEPATOCELLULAR CARCINOMA
    Saitta, C.
    Raffa, G.
    Casuscelli, F.
    Brancatelli, S.
    Alibrandi, A.
    Raimondo, G.
    Pollicino, T.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E30 - E30
  • [2] Impact of PIVKA-II in diagnosis of hepatocellular carcinoma
    Zakhary, Nadia I.
    Khodeer, Sherif M.
    Shafik, Hanan E.
    Malak, Camelia A. Abdel
    JOURNAL OF ADVANCED RESEARCH, 2013, 4 (06) : 539 - 546
  • [3] Evaluation of serum PIVKA-II (DCP) for the diagnosis of hepatocellular carcinoma.
    Wang, Y
    Koh, C
    Sokoll, LJ
    Chan, DW
    CLINICAL CHEMISTRY, 2001, 47 (06) : A133 - A133
  • [4] Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
    Pote, Nicolas
    Cauchy, Franois
    Albuquerque, Miguel
    Voitot, Helene
    Belghiti, Jacques
    Castera, Laurent
    Puy, Herve
    Bedossa, Pierre
    Paradis, Valerie
    JOURNAL OF HEPATOLOGY, 2015, 62 (04) : 848 - 854
  • [5] Performance evaluation of the Elecsys PIVKA-II and Elecsys AFP assays for hepatocellular carcinoma diagnosis
    Chan, Henry L. Y.
    Vogel, Arndt
    Berg, Thomas
    De Toni, Enrico N.
    Kudo, Masatoshi
    Trojan, Joerg
    Eiblmaier, Anja
    Klein, Hanns-Georg
    Hegel, Johannes Kolja
    Sharma, Ashish
    Madin, Kairat
    Rolny, Vinzent
    Lisy, Marcus-Rene
    Piratvisuth, Teerha
    JGH OPEN, 2022, 6 (05): : 292 - 300
  • [6] THE SIGNIFICANCE OF PIVKA-II TO HEPATOCELLULAR CARCINOMA PROGNOSIS
    Shamsdin, S. A.
    Zahmatkeshan, M.
    Badiee, P.
    Hashemzadeh, Z.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S311 - S311
  • [7] Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma
    Kaneko, Shun
    Kurosaki, Masayuki
    Tsuchiya, Kaoru
    Yasui, Yutaka
    Hayakawa, Yuka
    Inada, Kento
    Tanaka, Yuki
    Ishido, Shun
    Kirino, Sakura
    Yamashita, Koji
    Nobusawa, Tsubasa
    Matsumoto, Hiroaki
    Kakegawa, Tatsuya
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Takahashi, Yuka
    Nakanishi, Hiroyuki
    Izumi, Namiki
    PLOS ONE, 2022, 17 (03):
  • [8] PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
    Honglei Feng
    Bole Li
    Ze Li
    Qian Wei
    Li Ren
    BMC Cancer, 21
  • [9] Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma
    Guarneri, V.
    Loggi, E.
    Serra, C.
    Vukotic, R.
    Cevenini, M.
    Cursaro, C.
    Scuteri, A.
    Vitale, G.
    Margotti, M.
    Galli, S.
    Andreone, P.
    CLINICA CHIMICA ACTA, 2019, 493 : S147 - S147
  • [10] PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
    Feng, Honglei
    Li, Bole
    Li, Ze
    Wei, Qian
    Ren, Li
    BMC CANCER, 2021, 21 (01)
12345